Cell-based therapies for the treatment of rheumatoid arthritis

Autoimmune diseases, including rheumatoid arthritis that is the most prevalent rheumatic autoimmune disorder, affect autologous connective tissues caused by the breakdown of the self-tolerance mechanisms of the immune system. During the last two decades, cell-based therapy, including stem cells and none-stem cells has been increasingly considered as a therapeutic option in various diseases. This is partly due to the unique properties of stem cells that divide and differentiate from the specialized cells in the damaged tissue. Moreover, stem cells and none-stem cells, impose immunomodulatory properties affecting the diseases caused by immunological abnormalities such as rheumatic autoimmune disorders. In the present review, the efficacy of cell-based therapy with four main types of stem cells, including mesenchymal stem cells, hematopoietic stem cells, embryonic stem cells, and human amniotic membrane cells, as well as none-stem cells, including regulatory T cells, chimeric antigen receptor T cells, and tolerogenic dendritic cells will be evaluated. Moreover, other related issues, including safety, changes in immunological parameters, suitable choice of stem cell and none-stem cell origin, conditioning regimen, limitations, and complications will be discussed. Stem cell therapy for systemic sclerosis was evaluated. The efficacy of mesenchymal and hematopoietic stem cells was evaluated. Issues, including conditioning regimen, limitations, and complications, were discussedimage Cell-based therapy for rheumatoid arthritis was evaluated.Efficacies of stem cells and non-stem cell therapies were evaluated.Issues, including conditioning regimen, limitations, and complications, were discussed.

Automated summary

Cell-based therapy, including stem cells and non-stem cells, is considered as a therapeutic option for treating autoimmune diseases. The unique properties of stem cells, such as differentiation ability, can influence diseases caused by immunological abnormalities. The efficacy and related issues of cell-based therapy are evaluated and discussed through the assessment of different types of stem cells and non-stem cells.